Literature DB >> 6386887

Factors contributing to variability in drug pharmacokinetics. I. Absorption.

P G Welling, F L Tse.   

Abstract

Apart from the physical and chemical properties of a drug, and also the dosage form in which it is presented, many other factors may affect the absorption of orally administered compounds and give rise to variable systemic availability. Three such factors, gastrointestinal (GI) disease, drug-drug interactions, and drug-food interactions are considered here. Although information regarding these factors, particularly GI disease, is scarce and sometimes conflicting, it is clear that they may give rise to variable drug absorption. The wide spectrum of effects on different drugs precludes the application of general rules and guidelines in drug therapy in most cases. Drugs, dosage forms, and various interactions should be considered individually. Also the types of interactions described in this review must be combined with other factors to be discussed later in this series when considering the influence of variable absorption, distribution, metabolism, and excretion on drug pharmacokinetics and clinical efficacy.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6386887     DOI: 10.1111/j.1365-2710.1984.tb01075.x

Source DB:  PubMed          Journal:  J Clin Hosp Pharm        ISSN: 0143-3180


  4 in total

1.  Muscle contractures associated with glucocorticoid deficiency.

Authors:  R L Blandford; A K Samanta; A C Burden; F D Rosenthal
Journal:  Br Med J (Clin Res Ed)       Date:  1985-07-13

2.  Inter- and intra-subject variability of nitrendipine and the effects of food.

Authors:  J Lobo; D B Jack; M J Kendall
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 3.  Drug absorption in gastrointestinal disease and surgery. Clinical pharmacokinetic and therapeutic implications.

Authors:  P O Gubbins; K E Bertch
Journal:  Clin Pharmacokinet       Date:  1991-12       Impact factor: 6.447

Review 4.  Pharmacokinetic considerations in gastrointestinal motor disorders.

Authors:  G S Hebbard; W M Sun; F Bochner; M Horowitz
Journal:  Clin Pharmacokinet       Date:  1995-01       Impact factor: 6.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.